Latest Regulatory Delays News

CurveBeam AI Limited reported a remarkable 150% increase in device purchase orders in Q2 FY25, driven by strong demand for its HiRise™M platform and a new commercial agreement with Stryker. The company is advancing validation of its Enhanced HiRise™ for robotic surgical systems, despite a regulatory delay for its BMD SaaS module.

CurveBeam AI has reported a record quarter for HiRise™ device purchase orders, driven by a strategic expansion with Stryker in Australia and New Zealand. The company also advanced its FDA regulatory pathway for its BMD module, setting sights on mid-2025 submission.

Asara Resources has resumed exploration activities at its flagship Kada Gold Project in Guinea, appointing key technical consultants and preparing for a targeted drilling program to upgrade its mineral resource estimate.

Cooper Metals reports promising exploration progress at its Mt Isa East copper-gold project and high-grade gold assays at the Gooroo project, while maintaining a solid cash reserve of $2.1 million.

Pacific Edge announces a two-month delay in the Medicare Local Coverage Determination for its genetic oncology tests, extending the effective date to April 24, 2025. This extension follows the company’s active engagement with US regulatory bodies.

Infinity Lithium updates on regulatory feedback delaying its San José mining licence and pivots to larger European funding opportunities, signaling a strategic shift in project development.

Conrad Asia Energy reports solid progress in Q4 2024 with finalized gas sales agreements and promising LNG studies, despite delayed final investment decisions due to regulatory approvals.

Titanium Sands Limited confirms that retention applications for its lapsed Orion Exploration Licences are approved in principle, with formal renewals pending amid Sri Lankan regulatory delays. The company remains confident in progressing its Mannar Island Project and securing necessary environmental and mining approvals.